tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 115 are a HOLD (33.82%), 225 are a BUY (66.18%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 55.61% that have a potential upside of 46.29% achieved within 221 days.
Luca Issi’s has documented 656 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 30-Aug-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/28/2021. The price target of $150 was fulfilled within 1 day with a profit of $16.57 (12.42%) receiving and performance score of 124.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Apr-2023
$11
$8.98 (444.55%)
$12
Hold Since 21-Mar-2023
$3.85
$1.83 (90.59%)
$2.5
Buy Since 14-May-2025
$9
$6.98 (345.54%)
$9
Buy Since 05-Nov-2018
$8
$5.98 (296.04%)
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?
